Clinical Data Financial Statements
Clinical Data Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | March |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Clinical Data Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 63.7 | 68.8 | 56.4 |
| Gross Profit ($ mil.) | 22.8 | 22.8 | 20.4 |
| Operating Income ($ mil.) | (27.3) | (48.1) | 5.6 |
| Total Net Income ($ mil.) | (37.5) | (50.9) | 3.4 |
| Diluted EPS (Net Income) | (2.65) | (5.69) | 0.50 |
Clinical Data Quarterly Statements
| Quarter Ending Dec 07 | Quarter Ending Sep 07 | Quarter Ending Jun 07* | |
|---|---|---|---|
| Revenue ($ mil.) | 10.5 | 1.7 | 14.0 |
| Gross Profit ($ mil.) | 3.2 | (0.7) | 3.8 |
| Operating Income ($ mil.) | (14.5) | (13.7) | (4.5) |
| Total Net Income ($ mil.) | (4.3) | (10.9) | (5.4) |
| Diluted EPS (Net Income) | (0.17) | (0.59) | (0.36) |
- * Irregular reporting interval
Clinical Data Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | ||
| Price/Earnings Ratio | -- | ||
| Price/Book Ratio | -- | ||
| Price/Cash Flow Ratio | -- |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Clinical Data Financial Ratios
Clinical Data Competitive Intelligence
| Amgen | GlaxoSmithKline | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 14,771.0 | 22,716.0 | 48,418.0 |
| Employees | 17,500 | 103,401 | 86,600 |
| Market Cap ($ mil.) | 68,176.5 | -- | 129,966.4 |
Competitive Landscape
